Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy

JOURNAL OF HEPATOLOGY

卷:74

Article

Kushner, Tatyana¹  Reau, Nancy² 

[1] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA

[2] Rush Univ, Hepatol Serv, Med Ctr, Chicago, IL USA

关键词: Hepatitis C;    Pregnancy;    Mother-to-child tranmission;    Antiviral therapy;   

DOI  :  10.1016/j.jhep.2020.11.027

来源: Elsevier

【 摘 要 】

Despite the remarkable advances in HCV treatment brought about by the advent of direct-acting antivirals, HCV remains a global public health concern. One particular concern relates to the rising prevalence of HCV in women of childbearing age. Active HCV during pregnancy is associated with cholestasis of pregnancy as well as the risk of mother-to-child transmission. Guidelines are increasingly recommending universal screening during pregnancy, while the treatment of HCV during pregnancy is an area of ongoing research. (C) 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

【 授权许可】

Free